Tyrey L, Hammond C B
Am J Obstet Gynecol. 1976 May 15;125(2):160-5. doi: 10.1016/0002-9378(76)90586-x.
Antiserum generated against the hormone-specific beta-subunit of hCG uas used with different labeled antigens to measure circulating hCG in patients having trophoblastic disease. When 125 I-hCGbeta served as the labeled antigen, a small number of patient sera failed to show parallelism with the second IS-hCG reference and erroneous estimates of hormone concentrations were obtained. Replacement of the 125I-hCGbeta with labeled hCG corrected the nonparallelism exhibited by these samples. Inhibition curves obtained with purified hCG and hCGbeta suggested that both the nonparallelism and its correction with the change in labeled antigen would be consistent with the possibility that this assay aberration may result from the presence of free hCGbeta in these sera.
针对人绒毛膜促性腺激素(hCG)激素特异性β亚基产生的抗血清,与不同的标记抗原一起用于测量患有滋养层疾病患者的循环hCG。当125I-hCGβ作为标记抗原时,少数患者血清未能与第二个国际标准hCG参考品显示出平行关系,从而获得了错误的激素浓度估计值。用标记的hCG替代125I-hCGβ纠正了这些样本所表现出的不平行性。用纯化的hCG和hCGβ获得的抑制曲线表明,不平行性及其随标记抗原变化的校正都与这种检测异常可能是由于这些血清中存在游离hCGβ的可能性相一致。